• Miller BE and Sewell-Loftin MK. “Mechanoregulation of Vascular Endothelial Growth Factor Receptor 2 in Angiogenesis.” Frontiers in Cardiovascular Medicine, 8, 804934, 2022.
  • Guo Y, Miller B, Heim M, Gutierrez-Garcia AK, Sewell-Loftin MK, and Ren B. “Protocol for Indirect and Direct Co-Culture between Cancer Cells and Endothelial Cells.” In revision – Star Protocols, 2023.
  • Sewell-Loftin MK, Katz JB, George SC, and Longmore GD. “Micro-strains in the extracellular matrix induce angiogenesis.” Lab on a Chip, 20(15), 2776-2787.
  • Brenot AB, Sewell-Loftin MK, Lesage JL, Cornish DA, and Longmore GD. “Endothelial DDR2 is required for tumor angiogenesis and metastatis in breast cancer.” In preparation – Angiogenesis, 2023.
  • Qu X, Violette K, Sewell-Loftin MK, Soslow J, St. Jean L, Hinton RB, Zhou B, Merryman WD, and Baldwin HS, “Loss of Flow Responsive Tie1 Results in Impaired Aortic Valve Remodeling.”, Developmental Biology, Vol 455(1):73-84, 2019.
  • Sewell-Loftin MK, Bayer SVH, Crist EL, Hughes BT, Joison SM, Longmore GD, and George SC. “Cancer-associated fibroblasts support vascular growth through mechanical force.” Scientific Reports, 7 (1): 12574. doi: 10.1038/s41598-017-13006-x
  • Angel PM, Narmoneva DA, Sewell-Loftin MK, Munjal C, Dupuis L, Landis BJ, Jegga A, Kern CB, Merryman WD, Baldwin HS, Bressan GM, and Hinton RB. “Proteomic alterations associated with biomechanical dysfunction are early processes in the Emilin1 deficient mouse model of aortic valve disease.” Annals of Biomedical Engineering, 1-15, 2017.
  • Sewell-Loftin MK, Shiruie VS, Lam S, Todd TD, Hwang PY, and George SC. “Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis.” Tumor Organoids. Eds. Shay Shoker and Aleksander Skardal: Humana Press, Cham, Online-2017. 117-148. *Both authors contributed equally to this work.
  • Chen J, Ryzhova LM, Sewell-Loftin MK, Brown CB, Huppert SS, Baldwin HS, and Merryman WD, “Notch1 mutation leads to vavular calcification through enhanced myofibroblast mechanotransduction”, Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35(7): 1571605, 2015.
  • Sewell-Loftin MK, DeLaughter DM, Peacock JR, Brown CB, Baldwin HS, Barnett JV, and Merryman WD, “Myocardial contraction and hyaluronic acid mechanotransduction in epithelial to-mesenchymal transformation of endocardial cells”, Biomaterials, Vol. 35(9): 2809-2815, 2014.
  • Sewell-Loftin MK, Hampel ML, Frees AE, Blue LM, Lapp N, Zhang M, Robertson JM, Shah RR, and Brazel CS, “Magnetic Capture and Triggered Drug Release Using Iron Oxide Nanoparticles”, Nanomagnetic Actuation in Biomedicine: Basic Principles and Applications. Eds. Jon Dobson and Carlos Rinaldi, CRC Press, Online-2019. 147-174.
  • Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, and Merryman WD, “Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33: 114-120, 2013.
  • Sewell-Loftin MK, Brown CB, Baldwin HS, and Merryman WD, “Novel technique for quantifying mouse heart valve leaflet stiffness with atomic force microscopy,” Journal of Heart Valve Disease, Vol. 21(4): 513-520, 2012
  • Parekh A, Ruppender NS, Branch KM, Sewell-Loftin MK, Lin J, Boyer PD, Candiello JE, Merryman WD, Guelcher SA, and Weaver AM, “Sensing and modulation of invadopodia across a wide range of rigidities”, Biophysical Journal, Vol. 100(3): 573-82, 2011.
  • Sewell-Loftin MK, Chun YW, Khademhosseini A, and Merryman WD, “EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.” Journal of Cardiovascular Translational Research, Vol. 4(5): 658-71, 2011.
  • Sewell MK, Fugit KD, Ankareddi I, Zhang C, Hampel ML, Kim DH, and Brazel CS, “Magnetothermally-Triggered Drug Delivery Using Hydrogels with Imbedded Cobalt Ferrite, Iron Platinum or Manganese Ferrite Nanoparticles,” PMSE Preprints,Vol. 98:694-695, 2008.
  • Ankareddi I, Hampel ML, Sewell MK, Kim, DH, and Brazel CS, “Temperature Controlled Grafted Polymer Network Incorporated with Magnetic Nanoparticles to Control Drug Release Induced by an External Magnetothermal Trigger”, NSTI Nanotech, Vol 2: 431-434, 2007.